Buscar resultados de ensayos clínicos

Patrocinado por

Mesothelioma - 62 Studies Found

Estado Estudiar
Completed Nombre del estudio: Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma
Condición: Mesothelioma
Fecha: 2006-11-20
Intervenciones:
  • Drug: Cisplatin Starting Dose:
Completed Nombre del estudio: Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Condición: Mesothelioma
Fecha: 2005-08-29
Intervenciones:
  • Drug: Erlotinib Taken orally o
Completed Nombre del estudio: Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
Condición: Peritoneal Mesothelioma
Fecha: 2016-04-27
Intervenciones: Genetic: comparative genomic analysis DNA and RNA extraction will be performed in Lyon University hospit
Completed Nombre del estudio: SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural Mesothelioma
Condición: Mesothelioma
Fecha: 2011-09-30
Intervenciones:
  • Biological: Multicycle SS1P As
Withdrawn Nombre del estudio: A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma
Condición: Malignant Pleural Mesothelioma
Fecha: 2011-05-11
Intervenciones:
  • Drug: Cisplatin Cisplatin (75m
Completed Nombre del estudio: Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Condición: Mesothelioma
Fecha: 2010-09-15
Intervenciones: Drug: Zometa Zoledronic acid will be administered IV on the first day of a 21 day cycle at a concentrati
Active, not recruiting Nombre del estudio: Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
Condición:
  • Pleural Mesothelioma
  • Peritoneal Mesotheli
    Fecha: 2010-07-09
    Intervenciones: Drug: IMC-A12 20 mg/kg intravenous over 60 minutes or not to exceed 25 mg/minute once every 3 weeks (+ o
Completed Nombre del estudio: MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI
Condición: Mesothelioma
Fecha: 2026-01-11
Intervenciones: Intravenous infusion of magnesium sulfate prior to intraoperative chemotherapy with cisplatin.
Completed Nombre del estudio: Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Condición: Mesotheliomas Pleural
Fecha: 2026-01-11
Intervenciones: Pembrolizumab 200mg via IV infusion every 3 weeks for 2 cycles 3 pre-surgery, for 4 cycles post-surgery and then every 3 weeks during maintenance.
Completed Nombre del estudio: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Condición: Malignant Peritoneal Mesothelioma
Fecha: 2026-01-11
Intervenciones: Pemetrexed will be administered intravenously
<<< Previous | Next >>>